Russia's Enteromix Cancer Vaccine Shows 100% Success, Awaits Final Approval - Video

Russia's experimental mRNA-based cancer vaccine Enteromix has demonstrated 100% efficacy and safety in clinical trials, raising hopes for a breakthrough in the global fight against cancer. Developed using similar technology as COVID-19 vaccines, Enteromix works by training the immune system to recognize and eliminate cancer cells without serious side effects.The announcement was made by the Federal Medical and Biological Agency (FMBA) of Russia, with its head Veronika Skvortsova confirming that the vaccine had successfully completed preclinical studies and was now ready for clinical use.For more details, check out the full story on the link below:Russia's Enteromix Cancer Vaccine Shows 100% Success in Trial, Awaits Final Nod for Public Use